Form 4 for URGN UroGen Pharma Ltd.
Accepted 2025-10-09 00:00:00 ET · period of report 2025-10-08 · accession 0001437749-25-030772 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-09 | 2025-10-08 | URGN | Degnan Chris | CFO | M - OptEx | — | +4,483 | 4,483 | New | — |
| D | 2025-10-09 | 2025-10-08 | URGN | Degnan Chris | CFO | S - Sale+OE | $16.85 | -2,203 | 2,280 | -49% | -$37.1K |
| D | 2025-10-09 | 2025-10-08 | URGN | Degnan Chris | CFO | M - OptEx | $0.00 | -4,483 | 8,967 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-10-08 | M | A | 4,483 | — | 4,483 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 2 | Common | Ordinary Shares | 2025-10-08 | S | D | 2,203 | $16.85 | 2,280 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2025-10-08 | M | D | 4,483 | $0.00 | 8,967 | D | — · — to — | 4,483 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F3) The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025. |